The World Health Organization added BA.2.86, dubbed “Pirola” on social media by scientists closely tracking evolutionary changes in the virus, to its list of variants under monitoring Aug. 17. Shortly after, the CDC also said it has started tracking the lineage.
“CDC is gathering more information and will share more about this lineage as we learn it,” the agency said on the social media platform X, formerly known as Twitter. So far, BA.2.86 has been detected in Israel, Denmark, the U.S. and the U.K. So far, only six cases of the new strain have been identified, with the single U.S. case detected in Michigan.
As of right now, the main concerns are around the sheer number of changes the lineage has, which experts say is on par with the evolutionary jump that led to omicron’s emergence.
“This variant has lots of amino-acid mutations in spike: 33 relative to its putative BA.2,” the Bloom Lab said in an Aug. 16 tweet, adding that it’s also very different than XBB.1.5, which COVID-19 shots slated to arrive this fall were updated to target. “This makes it an evolutionary jump comparable in size to that which originally gave rise to micron,” the tweet said. Bloom Lab is run by Jesse Bloom, PhD, an evolutionary biologist at Seattle-based Fred Hutchinson Cancer Center.
For now, EG.5 remains the dominant strain in the U.S., according to the latest variant proportion updates from the CDC. BA.2.86 will continue to be grouped in with its distant parent BA.2 until it accounts for at least 1 percent of cases.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.